Cullinan Associates Inc. boosted its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,817 shares of the financial services provider’s stock after purchasing an additional 465 shares during the period. Cullinan Associates Inc.’s holdings in CME Group were worth $8,193,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in CME. Vanguard Group Inc. raised its holdings in shares of CME Group by 1.2% during the second quarter. Vanguard Group Inc. now owns 27,992,457 shares of the financial services provider’s stock valued at $5,433,616,000 after acquiring an additional 328,318 shares in the last quarter. Nuveen Asset Management LLC grew its holdings in shares of CME Group by 18,355.3% during the 2nd quarter. Nuveen Asset Management LLC now owns 3,238,530 shares of the financial services provider’s stock worth $628,631,000 after acquiring an additional 3,220,982 shares during the period. Parnassus Investments CA raised its position in shares of CME Group by 1.5% in the 3rd quarter. Parnassus Investments CA now owns 2,845,366 shares of the financial services provider’s stock worth $601,340,000 after acquiring an additional 41,326 shares in the last quarter. California Public Employees Retirement System raised its position in shares of CME Group by 11.5% in the 3rd quarter. California Public Employees Retirement System now owns 1,940,906 shares of the financial services provider’s stock worth $410,191,000 after acquiring an additional 200,245 shares in the last quarter. Finally, Amundi Pioneer Asset Management Inc. lifted its stake in shares of CME Group by 30.4% in the 2nd quarter. Amundi Pioneer Asset Management Inc. now owns 1,664,500 shares of the financial services provider’s stock valued at $323,097,000 after purchasing an additional 388,008 shares during the period. 84.14% of the stock is owned by institutional investors and hedge funds.

NASDAQ:CME traded up $1.45 on Wednesday, reaching $205.01. 1,160,071 shares of the stock traded hands, compared to its average volume of 1,365,628. The company has a market capitalization of $73.50 billion, a price-to-earnings ratio of 30.06, a PEG ratio of 3.47 and a beta of 0.18. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.14. CME Group Inc has a 12 month low of $161.05 and a 12 month high of $224.91. The company’s fifty day simple moving average is $203.77 and its 200 day simple moving average is $206.84.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.15. The business had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business’s revenue for the quarter was up 41.3% compared to the same quarter last year. During the same period in the previous year, the company earned $1.45 earnings per share. Equities analysts anticipate that CME Group Inc will post 6.83 EPS for the current fiscal year.

The company also recently declared a dividend, which will be paid on Wednesday, January 15th. Investors of record on Friday, December 27th will be given a dividend of $2.50 per share. The ex-dividend date is Thursday, December 26th. This is an increase from CME Group’s previous dividend of $1.75. CME Group’s dividend payout ratio (DPR) is 43.99%.

Several equities research analysts recently weighed in on CME shares. Citigroup upped their price target on CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. BidaskClub upgraded shares of CME Group from a “hold” rating to a “buy” rating in a report on Friday, January 10th. Sanford C. Bernstein lowered shares of CME Group from an “outperform” rating to a “market perform” rating in a research note on Friday, January 10th. UBS Group lifted their price target on shares of CME Group from $218.00 to $221.00 and gave the company a “neutral” rating in a research report on Wednesday, December 4th. Finally, Credit Suisse Group initiated coverage on shares of CME Group in a research note on Monday, December 16th. They set a “neutral” rating on the stock. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the company. CME Group has an average rating of “Hold” and a consensus price target of $208.36.

In other news, Director Martin J. Gepsman sold 1,000 shares of the company’s stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $201.16, for a total transaction of $201,160.00. Following the transaction, the director now directly owns 34,905 shares of the company’s stock, valued at $7,021,489.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Ronald A. Pankau sold 300 shares of the company’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $199.02, for a total value of $59,706.00. Following the transaction, the director now directly owns 3,906 shares in the company, valued at $777,372.12. The disclosure for this sale can be found here. Insiders have sold 40,609 shares of company stock valued at $8,216,221 in the last three months. 1.20% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Cash Flow

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.